Cited In for PMID: 31974557

Year	Number of Results
2020	1
2021	3
2022	3
2024	2
2025	0

1

Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism.

Dawwas GK, Smith SM, Dietrich E, Lo-Ciganic WH, Park H. Dawwas GK, et al. Am J Health Syst Pharm. 2020 Jan 24;77(3):188-195. doi: 10.1093/ajhp/zxz307. Am J Health Syst Pharm. 2020. PMID: 31974557

2

Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.

Bertoletti L, Gusto G, Khachatryan A, Quignot N, Chaves J, Moniot A, Mokgokong R. Bertoletti L, et al. Thromb Haemost. 2022 Aug;122(8):1384-1396. doi: 10.1055/a-1731-3922. Epub 2022 Jan 4. Thromb Haemost. 2022. PMID: 34983073 Free PMC article.

3

Real-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia.

Al Yami MS, Alzahrani MY, Alshehri AM, Alshaya OA, Alsubiae NS, Alharbi YM, Albaiahy LK, Aldeiban M, Alkuait HA, Alobaidi W, Aldawsari A, Almutairi NM, Alshibani M, Korayem GB, Alfayez OM, Almutairi AR, Almohammed OA. Al Yami MS, et al. Int J Gen Med. 2021 Jul 28;14:4031-4037. doi: 10.2147/IJGM.S322221. eCollection 2021. Int J Gen Med. 2021. PMID: 34349553 Free PMC article.

4

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.

Beyer-Westendorf J, Marten S, Tittl L, Naue C, Bornhäuser M. Beyer-Westendorf J, et al. TH Open. 2021 May 4;5(2):e143-e151. doi: 10.1055/s-0041-1728675. eCollection 2021 Apr. TH Open. 2021. PMID: 33969261 Free PMC article.

5

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.

Cohen AT, Sah J, Dhamane AD, Lee T, Rosenblatt L, Hlavacek P, Emir B, Delinger R, Yuce H, Luo X. Cohen AT, et al. Thromb Haemost. 2022 Jun;122(6):926-938. doi: 10.1055/s-0041-1740254. Epub 2021 Dec 28. Thromb Haemost. 2022. PMID: 34963185 Free PMC article.

6

Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis.

Alshahrani WA, Alshahrani RS, Alkathiri MA, Alay SM, Alabkka AM, Alaraj SA, Al Yami MS, Altayyar WA, Alfayez OM, Basoodan MS, Almutairi AR, Almohammed OA. Alshahrani WA, et al. Am J Cardiovasc Drugs. 2024 Nov;24(6):823-839. doi: 10.1007/s40256-024-00677-x. Epub 2024 Sep 10. Am J Cardiovasc Drugs. 2024. PMID: 39254826

7

Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE).

Coons JC, Anupindi VR, Doshi R, DeKoven M, Dai F, Russ C, Stellhorn R, Cheng D, Shi L, Deeba S, Hines DM. Coons JC, et al. J Clin Med. 2024 Jun 15;13(12):3512. doi: 10.3390/jcm13123512. J Clin Med. 2024. PMID: 38930040 Free PMC article.

8

Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.

Pawar A, Gagne JJ, Gopalakrishnan C, Iyer G, Tesfaye H, Brill G, Chin K, Bykov K. Pawar A, et al. JAMA. 2022 Mar 15;327(11):1051-1060. doi: 10.1001/jama.2022.1920. JAMA. 2022. PMID: 35289881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 31974557

8 results

Results by year